Literature DB >> 15897741

Distribution of cytokeratins and vimentin in adult renal neoplasms and normal renal tissue: potential utility of a cytokeratin antibody panel in the differential diagnosis of renal tumors.

Brian F Skinnider1, Andrew L Folpe, Randolph A Hennigar, So Dug Lim, Cynthia Cohen, Pheroze Tamboli, Andrew Young, Mariza de Peralta-Venturina, Mahul B Amin.   

Abstract

Adult renal epithelial neoplasms (RENs) comprise several distinct clinicopathologic entities with potential prognostic and therapeutic differences. Individual cases can show overlapping morphologic features, necessitating the use of ancillary methods. The purpose of this study was to determine the diagnostic utility of cytokeratin (CK) subtype expression pattern in a wide range of adult RENs. RENs (including clear cell [conventional] renal cell carcinoma (RCC), papillary RCC, chromophobe RCC, renal oncocytoma, collecting duct carcinoma (CDC), renal medullary carcinoma (RMC), urothelial carcinoma, metanephric adenoma (MA), tubulocystic carcinoma (TC) (also known as low-grade collecting duct carcinoma), and mucinous tubular and spindle cell carcinoma) were immunostained for CK subtypes (CK5/CK6, 7, 8, 13, 14, 17, 18, 19, 20), high molecular weight CKs 1, 5, 10, 14 (HMWCK), and vimentin (Vim). The expression pattern of normal kidney was also examined and correlated with RENs. Although there is some overlap, subtypes of RENs show distinctive CK expression profiles that may be useful in several differential diagnostic settings. Clear cell RCCs typically showed a restricted expression pattern of CK8, CK18 and Vim. Papillary RCCs typically expressed CK7, CK8, CK18, CK19, and Vim and could be distinguished from MA (CK7-). Chromophobe RCCs were typically CK7+, CK8+, CK18+, and Vim-, and could be distinguished from oncocytomas (typically CK7-). In oncocytomas, nonspecific staining of unblocked endogenous biotin is a potentially significant diagnostic pitfall. CDC, RMC, and TC demonstrated similar CK expression profiles (with the exception of HMWCK expression limited to CDC), supporting a close relationship between these entities. A panel of CK5/CK6, CK17, and Vim may be helpful in distinguishing CDC (typically CK5/CK6-, CK17-, Vim+) and urothelial carcinoma (typically CK5/CK6+, CK17+, Vim-). In conclusion, CK expression patterns may be helpful in several differential diagnostic situations when dealing with adult RENs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15897741     DOI: 10.1097/01.pas.0000163362.78475.63

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  54 in total

1.  Renal tumors: diagnostic and prognostic biomarkers.

Authors:  Puay Hoon Tan; Liang Cheng; Nathalie Rioux-Leclercq; Maria J Merino; George Netto; Victor E Reuter; Steven S Shen; David J Grignon; Rodolfo Montironi; Lars Egevad; John R Srigley; Brett Delahunt; Holger Moch
Journal:  Am J Surg Pathol       Date:  2013-10       Impact factor: 6.394

2.  Metastatic renal oncocytoma.

Authors:  J D Oxley; J Sullivan; A Mitchelmore; D A Gillatt
Journal:  J Clin Pathol       Date:  2007-06       Impact factor: 3.411

3.  Family portrait: renal progenitor of Bowman's capsule and its tubular brothers.

Authors:  Paola Romagnani
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

4.  Isolation and characterization of progenitor-like cells from human renal proximal tubules.

Authors:  David Lindgren; Anna-Karin Boström; Kristina Nilsson; Jennifer Hansson; Jonas Sjölund; Christina Möller; Karin Jirström; Elise Nilsson; Göran Landberg; Håkan Axelson; Martin E Johansson
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

5.  Expression of KRT7 and WT1 differentiates precursor lesions of Wilms' tumours from those of papillary renal cell tumours and mucinous tubular and spindle cell carcinomas.

Authors:  Adrianna Szponar; Gyula Kovacs
Journal:  Virchows Arch       Date:  2012-03-02       Impact factor: 4.064

6.  Immunohistochemical and electronmicroscopic features of mesenchymal-to-epithelial transition in human developing, postnatal and nephrotic podocytes.

Authors:  Natalija Filipovic; Katarina Vukojevic; Ivana Bocina; Marijan Saraga; Merica Glavina Durdov; Boris Kablar; Mirna Saraga-Babic
Journal:  Histochem Cell Biol       Date:  2016-10-01       Impact factor: 4.304

7.  A Comprehensive Study of Progressive Cytogenetic Alterations in Clear Cell Renal Cell Carcinoma and a New Model for ccRCC Tumorigenesis and Progression.

Authors:  Zhongfa Zhang; Bill Wondergem; Karl Dykema
Journal:  Adv Bioinformatics       Date:  2010-07-05

8.  Metanephric adenoma of the kidney: an unusual diagnostic challenge.

Authors:  Sri J Obulareddy; Junqing Xin; Alexander M Truskinovsky; James K Anderson; Michael J Franklin; Arkadiusz Z Dudek
Journal:  Rare Tumors       Date:  2010-06-30

9.  Mucinous tubular and spindle cell carcinoma of the kidney with sarcomatoid differentiation.

Authors:  Rochelle A Simon; P Anthony di Sant'agnese; Ganesh S Palapattu; Eric A Singer; Grace D Candelario; Jiaoti Huang; Jorge L Yao
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

Review 10.  Chromophobe renal cell cancer--review of the literature and potential methods of treating metastatic disease.

Authors:  Rafał Stec; Bartłomiej Grala; Michał Maczewski; Lubomir Bodnar; Cezary Szczylik
Journal:  J Exp Clin Cancer Res       Date:  2009-10-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.